Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

NCT01438775 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
192
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nymox Corporation